Regeneron Pharmaceuticals has announced that the European Commission has conditionally approved Lynozyfic (linvoseltamab) for ...

Groundbreaking research has identified over 900 genetic links to osteoarthritis, including 500 previously undiscovered, in a study involving Sheffield Teaching Hospitals NHS Foundation Trust.

Takeda has announced a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending European ...

Wilczewski CM, Obasohan J, Paschall JE, Zhang S, Singh S, Maxwell GL, Similuk M, Wolfsberg TG, Turner C, Biesecker LG, Katz ...

Women in Pharma founders reflect on their progress and ambitions ...

Argenx has announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended European Commission (EC) ...

If you ask AI about the future of cancer care, it replies that it will ‘make cancer care more precise, proactive and ...

It is not a one-time problem to solve but a constantly morphing puzzle with evolving guidelines, regional differences and ...

Generative AI has already disrupted entire industries – leaving knowledge workers reeling. For a time, the technology’s ...

As we move into the second half of the decade, AI – particularly science-aware AI – seems destined to transform biopharma R&D ...

At the heart of this evolution are Smart Hospitals – facilities that harness advanced technologies to enhance patient care, ...

For decades, women were significantly underrepresented in clinical trials. Recent years have seen improvement, but there are ...